Neil A. Bhowmick
Affiliations: | Vanderbilt University, Nashville, TN | ||
| Biomedical Sciences | Cedars-Sinai Medical Center, Los Angeles, CA, United States |
Area:
Cell Biology, General Biology, Molecular Biology, OncologyWebsite:
http://bio.csmc.edu/view/15003/Neil-Bhowmick.aspxGoogle:
"Neil Bhowmick"Bio:
http://www.mc.vanderbilt.edu/reporter/index.html?ID=3027
https://books.google.com/books?id=dZIvAQAAIAAJ
Parents
Sign in to add mentor| John David Puett | grad student | 1998 | University of Georgia (Chemistry Tree) | |
| (Structure-function analysis of the binding and ligand-mediated down regulation of the lutropin and endothelin A receptors.) | ||||
| Harold L. Moses | research scientist | Vanderbilt | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gong J, Kim DM, Freeman MR, et al. (2023) Genetic and biological drivers of prostate cancer disparities in Black men. Nature Reviews. Urology |
| Gong J, Kim DM, De Hoedt AM, et al. (2023) Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300949 |
| Borah S, Mishra R, Dey S, et al. (2023) Corrigendum to "Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism" [Mitochondrion 71 (2023) 40-49]. Mitochondrion. 71: 63 |
| Borah S, Mishra R, Dey S, et al. (2023) Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism. Mitochondrion. 71: 40-49 |
| Bhowmick N, Posadas E, Ellis L, et al. (2023) Targeting Glutamine Metabolism in Prostate Cancer. Frontiers in Bioscience (Elite Edition). 15: 2 |
| Mishra R, Haldar S, Biondi S, et al. (2022) TGF-β controls stromal telomere length through epigenetic modifications. 3 Biotech. 12: 290 |
| Bhowmick S, Bhowmick NA. (2022) RARγ: The Bone of Contention for Endothelial Cells in Prostate Cancer Metastasis. Cancer Research. 82: 2975-2976 |
| Smith BN, Mishra R, Billet S, et al. (2022) Antagonizing CD105 and Androgen Receptor to Target Stromal-Epithelial Interactions for Clinical Benefit. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Zhang L, Billet S, Gonzales G, et al. (2022) Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner. Cancers. 14 |
| LeVee A, Lin CY, Posadas E, et al. (2021) Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. Oncotargets and Therapy. 14: 4819-4832 |